Beta-glucuronidase high: what stool enzyme activity means

Published October 7, 2026 · Updated November 1, 2026 · 4 min read

High beta-glucuronidase on a stool report means the measured enzyme activity is above that laboratory’s range. It is not a blood estrogen measurement, a liver-function test or a cancer-risk score. The result is most useful when its limits are kept separate from claims about “detox” or hormone balance.

On this page

Why the enzyme is discussed with estrogen

Laboratory research has shown that some gut microbial beta-glucuronidase enzymes can reactivate particular estrogen compounds. That establishes a biochemical mechanism under study. It does not validate a GI-MAP result as a diagnosis of “estrogen dominance,” a cancer-risk score or a personalized hormone-treatment tool. [1]

What GI-MAP reports

The intestinal-health section includes a beta-glucuronidase activity measurement. This differs from the panel’s microbial DNA quantities. A high activity value does not identify which organism contributed most, nor does it measure every step of hormone processing. [2]

What high or low activity cannot establish

A high flag cannot show that the enzyme caused a symptom, that toxins are building up in the body or that a supplement is required. A low result does not prove impaired hormone production or a need to raise the enzyme.

The assay’s reference range belongs to that laboratory method. Values from another stool test, a genetic enzyme disorder investigation or a research experiment may not use the same units or answer the same clinical question.

How to discuss a proposed intervention

Ask what health outcome is being targeted, what evidence supports the intervention for that outcome and how benefit would be assessed. Lowering an enzyme number is not automatically equivalent to improving hormone symptoms or reducing disease risk. Do not change prescribed hormone therapy on the basis of this stool marker alone.

From an enzyme mechanism to a health claim: what is missing?

Beta-glucuronidase removes glucuronic acid from certain molecules. This is called deconjugation. Adding glucuronic acid and removing it are different biochemical steps; the stool assay does not measure the entire pathway or everything the body eliminates.

In a laboratory study, researchers tested 35 human gut microbial beta-glucuronidase enzymes and found that some could reactivate particular estrogen compounds. The work included purified enzymes and mouse-related experiments, not a clinical trial showing that treating a high GI-MAP result improves a person’s hormone symptoms. An inhibitor also did not reduce tumor development in the mouse model studied. [1]

That distinction matters when reading supplement advertising. Evidence that an enzyme can perform a reaction is not evidence that a particular person has excessive estrogen, that the stool marker caused a symptom, or that lowering it produces a clinical benefit.

A practical checklist for a high result

  1. Confirm what was measured. This is an activity assay, unlike the microbial DNA quantities elsewhere on the report. Compare the units and reference range on the actual laboratory document.
  2. Define the symptom or concern. A hormone-related symptom, a medication question and a digestive symptom may require different clinical assessments.
  3. Examine the intervention claim. Ask whether a proposed supplement was studied in people with your condition, what outcome improved and whether it interacts with your medicines.
  4. Set a useful follow-up goal. A lower enzyme value alone does not show that hormone levels, symptoms or long-term health risks improved.

A high Bacteroides fragilis quantity and a high enzyme activity value can occur on the same report, but that pairing does not prove that this species caused the activity result. Species abundance and enzyme function are different measurements.

Common questions

Can this result diagnose high estrogen?

No. It measures a stool enzyme activity, not circulating hormone concentrations.

Does it tell me which bacterium to eliminate?

No. An aggregate enzyme measurement does not identify a single causal organism or establish that eradication is appropriate.

Should I take calcium D-glucarate for a high result?

The stool result alone does not establish that you need it or that it will improve your symptoms. Ask your clinician about evidence for your specific concern and potential interactions before using a supplement.

Is low beta-glucuronidase always a problem?

No. First check whether the laboratory actually flags the value as abnormal and what the assay range means. A lower activity result does not diagnose a hormone deficiency or establish a need to raise the enzyme.

Sources and review

Sources checked November 1, 2026. Manufacturer material describes the test; clinical guidance and research support the interpretation limits.

  1. Ervin et al.: Gut microbial beta-glucuronidases and estrogen reactivation, 2019
  2. Diagnostic Solutions Laboratory: GI-MAP interpretive guide (manufacturer specifications)

This article, including the November 1 update, has been reviewed by Madison Ordway, FDN-P. For a correction or source question, contact Gi Map Test.